Phase IIA, Single-Arm, Open- Label, Clinical Trial of Calcipotriene Plus 5-fluorouracil Immunotherapy for Skin Cancer Prevention in Organ Transplant Recipients
Latest Information Update: 09 Dec 2024
At a glance
- Drugs Calcipotriol (Primary) ; Fluorouracil (Primary)
- Indications Actinic keratosis; Skin cancer
- Focus Therapeutic Use
Most Recent Events
- 11 May 2024 Planned End Date changed from 1 Mar 2027 to 1 Feb 2029.
- 13 Apr 2024 Planned primary completion date changed from 1 Mar 2027 to 1 Feb 2027.
- 13 Apr 2024 Status changed from not yet recruiting to recruiting.